F.L. Shapiro

2.1k total citations
54 papers, 1.6k citations indexed

About

F.L. Shapiro is a scholar working on Radiation, Hematology and Molecular Biology. According to data from OpenAlex, F.L. Shapiro has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiation, 11 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in F.L. Shapiro's work include Nuclear Physics and Applications (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Atomic and Subatomic Physics Research (7 papers). F.L. Shapiro is often cited by papers focused on Nuclear Physics and Applications (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Atomic and Subatomic Physics Research (7 papers). F.L. Shapiro collaborates with scholars based in United States, Russia and France. F.L. Shapiro's co-authors include Shahin Rafii, AS Asch, Barbara Ferris, Carol Aghajanian, D. Fennelly, William F. Keane, Leopoldo Raij, Larry Norton, RL Nachman and Ruth Pettengell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Kidney International.

In The Last Decade

F.L. Shapiro

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F.L. Shapiro United States	19	445	372	349	242	206	54	1.6k
Federico Moscardó Spain	27	933 2.1×	452 1.2×	386 1.1×	91 0.4×	257 1.2×	104	2.2k
Don A. Gabriel United States	28	888 2.0×	173 0.5×	261 0.7×	231 1.0×	141 0.7×	100	2.2k
Yoshiki Yamashita Japan	24	282 0.6×	206 0.6×	301 0.9×	229 0.9×	359 1.7×	137	2.1k
Robert M. Langdon United States	15	215 0.5×	739 2.0×	261 0.7×	60 0.2×	170 0.8×	29	1.6k
Eiichi Tanaka Japan	21	147 0.3×	210 0.6×	113 0.3×	225 0.9×	69 0.3×	69	1.7k
Seymour H. Levitt United States	41	224 0.5×	988 2.7×	699 2.0×	912 3.8×	159 0.8×	218	5.4k
Kenneth R. Kase United States	27	214 0.5×	247 0.7×	318 0.9×	94 0.4×	114 0.6×	92	2.1k
R. Willers Germany	19	113 0.3×	166 0.4×	236 0.7×	188 0.8×	60 0.3×	37	981
Alan H. Stolpen United States	26	109 0.2×	172 0.5×	247 0.7×	531 2.2×	388 1.9×	69	2.7k
Shiro Miwa Japan	28	232 0.5×	523 1.4×	430 1.2×	995 4.1×	110 0.5×	198	2.8k

Countries citing papers authored by F.L. Shapiro

Since Specialization

Citations

This map shows the geographic impact of F.L. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.L. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.L. Shapiro more than expected).

Fields of papers citing papers by F.L. Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.L. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.L. Shapiro. The network helps show where F.L. Shapiro may publish in the future.

Co-authorship network of co-authors of F.L. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of F.L. Shapiro. A scholar is included among the top collaborators of F.L. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.L. Shapiro. F.L. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vanderstichele, Hugo, Geert De Meyer, F.L. Shapiro, et al.. (2008). Alzheimer’s disease biomarkers: from concept to clinical utility. 81–122. 23 indexed citations

Aghajanian, Carol, D. Fennelly, F.L. Shapiro, et al.. (1998). Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.. Journal of Clinical Oncology. 16(5). 1852–1860. 39 indexed citations

Fennelly, D., Carol Aghajanian, F.L. Shapiro, et al.. (1997). Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.. Journal of Clinical Oncology. 15(1). 187–192. 220 indexed citations

Shapiro, F.L., T. J. Yao, Craig H. Moskowitz, et al.. (1997). Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.. PubMed. 3(9). 1571–8. 11 indexed citations

Shapiro, F.L., Bronislaw Pytowski, Shahin Rafii, et al.. (1996). The Effects of Flk-2/flt3 Ligand as Compared with c-kit Ligand on Short-Term and Long-Term Proliferation of CD34+ Hematopoietic Progenitors Elicited from Human Fetal Liver, Umbilical Cord Blood, Bone Marrow, and Mobilized Peripheral Blood. Journal of Hematotherapy. 5(6). 655–662. 17 indexed citations

Gogas, Helen, F.L. Shapiro, Carol Aghajanian, et al.. (1996). The Impact of Diabetes Mellitus on the Toxicity of Therapy for Advanced Ovarian Cancer. Gynecologic Oncology. 61(1). 22–26. 45 indexed citations

Shapiro, F.L., et al.. (1994). Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. Blood. 84(10). 3567–3574. 59 indexed citations

Cosio, Fernando G., et al.. (1981). Severe renal failure in multiple myeloma.. PubMed. 15(4). 206–10. 44 indexed citations

Shapiro, F.L., et al.. (1979). Metabolic effect of fluoxymesterone in chronic hemo dialysis patients. Kidney International. 16(6). 886. 1 indexed citations

10.

Wathen, Ronald L., Prakash Keshaviah, & F.L. Shapiro. (1978). Unsolved technical problems of maintenance dialysis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9(4). 174–8.

11.

Keane, William F., F.L. Shapiro, & Leopoldo Raij. (1977). INCIDENCE AND TYPE OF INFECTIONS OCCURRING IN 445 CHRONIC HEMODIALYSIS PATIENTS. ASAIO Journal. 23(1). 41–46. 116 indexed citations

12.

Shapiro, F.L., et al.. (1976). Ferromagnetic gates for ultracold neutrons. 1 indexed citations

13.

Wathen, Ronald L., et al.. (1974). Prescription water for chronic hemodialysis.. PubMed. 20A. 189–96. 12 indexed citations

14.

Wathen, Ronald L., et al.. (1974). The comparison of low flow (QD 200) to regular flow QD 500) dialysis.. PubMed. 20A. 402–8. 3 indexed citations

15.

Shapiro, F.L., et al.. (1964). Neutron polarization by transmission through a polarized proton target. Physics Letters. 12(4). 334–337. 17 indexed citations

16.

Buras, B., et al.. (1964). THE TIME-OF-FLIGHT METHOD FOR NEUTRON CRYSTAL STRUCTURE INVESTIGATIONS AND ITS POSSIBILITIES IN CONNECTION WITH VERY HIGH FLUX REACTORS. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 3 indexed citations

17.

Popov, Yu. P. & F.L. Shapiro. (1962). ENERGY DEPENDENCE OF THE CROSS SECTIONS FOR (n,$gamma$)-REACTIONS OF A NUMBER OF ODD-Z NUCLEI. Zhur. Eksptl'. i Teoret. Fiz.. 1 indexed citations

18.

Shapiro, F.L.. (1961). THE MÖSSBAUER EFFECT. Soviet Physics Uspekhi. 3(6). 881–887. 8 indexed citations

19.

Martı̂nez, Javier, F.L. Shapiro, & R A Good. (1959). Absence of Gene Interaction in Mouse Hybrids, Revealed by Studies of Immunological Tolerance and Homotransplantation.. Experimental Biology and Medicine. 101(4). 658–660. 9 indexed citations

20.

Bergman, A. A., et al.. (1958). MEASUREMENTS WITH A SLOWING-DOWN-TIME NEUTRON SPECTROMETER EMPLOYING LEAD. EXCITED LEVEL OF THE He$sup 4$ NUCLEUS. Journal of Experimental and Theoretical Physics. 6. 6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact